The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006
Neutropenia in lung cancer cases after chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 753s Year: 2006
Efficacy of darbepoietin alfa in anemia developed during chemotherapy for lung cancer Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
The safety and efficacy of treatment with nab-paclitaxel and carboplatin for patients with advanced squamous non-small cell lung cancer with interstitial lung disease. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Dexamethasone improves antiemetic control in lung cancer patients treated with chemotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 434s Year: 2007
Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006
Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 76s Year: 2005
Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer Source: ERJ Open Res, 4 (2) 00120-2017; 10.1183/23120541.00120-2017 Year: 2018
Postoperative lung cancer relapse after chemoradiation therapy Source: International Congress 2014 – Thoracic oncology grand round - an interactive session Year: 2014
Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001
Efficacy and safety of erythropoietic agents in anaemic patients with lung cancer (LC) Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Efficacy and safety of amurubicin (AMR) for the elderly with refractory relapse small cell lung cancer (SCLC) who had previous treatment Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer? Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011